JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-01-24DOI: 10.1016/j.jfop.2024.100084
A.S. Bonte , R.J.W. de Keizer , V. De Groot , A. Vandendriessche , K. Van Oevelen , N. Lauwers
{"title":"A Merkel cell carcinoma of the eyelid after previously diagnosed and treated conjunctival intraepithelial neoplasia: a case report","authors":"A.S. Bonte , R.J.W. de Keizer , V. De Groot , A. Vandendriessche , K. Van Oevelen , N. Lauwers","doi":"10.1016/j.jfop.2024.100084","DOIUrl":"10.1016/j.jfop.2024.100084","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100084"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000084/pdfft?md5=7a63391dfe59f7b255283ee6c4c65b25&pid=1-s2.0-S2949889924000084-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139638111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-01-18DOI: 10.1016/j.jfop.2024.100078
Niranjana J., Deepsekhar Das, Abhijeet Beniwal
{"title":"Erlotinib-induced trichomegaly in a patient with metastatic lung cancer","authors":"Niranjana J., Deepsekhar Das, Abhijeet Beniwal","doi":"10.1016/j.jfop.2024.100078","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100078","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100078"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000023/pdfft?md5=e8c88bb7a266367a019597471bfe2ae7&pid=1-s2.0-S2949889924000023-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139487550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Outcomes of phaco-trabeculectomy versus phaco-viscocanalostomy for primary open angle glaucoma","authors":"Mahdi Sharifzadeh Kermani, Maryam Abbasi Moghaddam, Mahla Shadravan, Ali Sharifi, Arash Daneshtalab, Amin Zand","doi":"10.1016/j.jfop.2024.100091","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100091","url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to compare the intraocular pressure (IOP)-lowering effect and postoperative adverse effects of combined phacoemulsification and trabeculectomy (PT) and combined phacoemulsification and viscocanalostomy (PVC) in eyes with primary open-angle glaucoma (POAG).</p></div><div><h3>Methods</h3><p>In this prospective study, eighty-one consecutive patients (81 eyes) with POAG and cataract were enrolled. The eyes were randomly assigned to either the PT group (40 eyes) or the PVC group (41 eyes). The main outcomes included the success rate based on IOP and the evaluation of adverse effects during the 6-month follow-up period. The surgery was considered a complete success if the IOP was between 6 and 20 mmHg and reduced by ≥30% without glaucoma medications or additional surgery compared to the preoperative level. A qualified success was characterized by an IOP within the range of 6−20 mmHg and a 20−30% reduction in IOP achieved through the use of glaucoma medications.</p></div><div><h3>Results</h3><p>The mean baseline IOP was 23.20 ± 7.94 mmHg in the PT group and 21.29 ± 6.81 mmHg in the PVC group (<em>P</em> = 0.249). At 6 months, the mean postoperative IOP in the PT and PVC groups were 13.50 ± 2.49, and 13.73 ± 1.70, respectively. There was no significant difference in mean IOP between the groups at any time (<em>P</em> > 0.05). At 6 months, 22 patients (55%) in the PT group and 22 patients (53.66%) in the PVC group achieved complete success. Nine eyes (22.50%) in the PT group and 10 eyes (24.39%) in the PVC group achieved qualified success. The other patients (9 eyes in each group) did not meet the criteria for at least a qualified success and were considered failures (<em>P</em> = 0.980). Intraoperative microperforation of Descemet's membrane occurred in 2 cases (15%) in the PVC group. Postoperative complications included 4 cases (10%) of shallow/flat anterior chamber, 1 case (2.5%) of choroidal effusion, and 1 case (2.5%) of aqueous misdirection in the PT group. The rate of these postoperative adverse effects was not significant between the two groups (<em>P</em> > 0.05).</p></div><div><h3>Conclusions</h3><p>There was no significant difference in IOP reduction between PT and PVC in patients with POAG. Furthermore, PVC is safe enough in these patients, compared to PT.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100091"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000151/pdfft?md5=23aefc595ffb4b97ec39b43326d588b9&pid=1-s2.0-S2949889924000151-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140000272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-02-07DOI: 10.1016/j.jfop.2024.100086
Manu Saini , Usha Singh , Arun K. Jain , Shweta Chaurasia , Manpreet Singh , Kulbhushan Saini , Aditi Mehta , Nripen Gaur , Pankaj Gupta
{"title":"Surgical adjustment of eyelid contour symmetry using three-point topography of the contralateral eyelid in unilateral congenital ptosis","authors":"Manu Saini , Usha Singh , Arun K. Jain , Shweta Chaurasia , Manpreet Singh , Kulbhushan Saini , Aditi Mehta , Nripen Gaur , Pankaj Gupta","doi":"10.1016/j.jfop.2024.100086","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100086","url":null,"abstract":"<div><h3>Purpose</h3><p>To appraise the efficiency of three differential horizontal double-armed suture placements based on the topographic mapping of the contralateral normal eyelid in external levator aponeurosis surgery for unilateral congenital ptosis.</p></div><div><h3>Methods</h3><p>A Retrospective study, including unilateral congenital ptosis who underwent external levator aponeurosis surgery utilizing a differential suture placement technique, was performed. Preoperative demographics and clinical data were reviewed. Preoperative and postoperative photographs in the primary position were used for determining any asymmetry in upper and lower eyelid contour, MRD1 and MRD2 with respect to the normal contralateral eyelid, analysed by Fiji image J software.</p></div><div><h3>Results</h3><p>Eleven eyelids of 11 unilateral congenital ptosis patients with a mean age of 21.18 ± 1.33 years were enrolled in this study. Mean MRD1 Pre/Post levator surgery at 3-month follow-up was 0.512 ± 0.775/3.291 ± 0.982 mm (P = 0.00). The upper eyelid contour of the ptotic eyelid at 3-month post external levator aponeurosis surgery and contralateral eyelid were 0.93 ± 0.44/0.88 ± 0.41 (P = 0.533). There was no observed significant difference noted in MRD2 and lower eyelid contour (P = 0.092/P = 0.876) on comparison with the contralateral eyelid, following differential levator aponeurosis surgery at a 3-month follow-up visit.</p></div><div><h3>Conclusion</h3><p>The study emphasises the routine practice of contralateral eyelid threepoint topography measurement in unilateral congenital ptosis correction surgery to simplify the contour adjustment and obviate the need for frequent suture replacement.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100086"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000102/pdfft?md5=83c646cf428a45e556b64c41799d62fa&pid=1-s2.0-S2949889924000102-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139713694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-02-16DOI: 10.1016/j.jfop.2024.100090
Justin Grad , Amin Hatamnejad , Niveditha Pattathil , John Golding , Samantha Orr , Netan Choudhry
{"title":"Inferior chorioretinal coloboma in a 29-year-old male referred for suspected posterior staphyloma: a case report","authors":"Justin Grad , Amin Hatamnejad , Niveditha Pattathil , John Golding , Samantha Orr , Netan Choudhry","doi":"10.1016/j.jfop.2024.100090","DOIUrl":"https://doi.org/10.1016/j.jfop.2024.100090","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100090"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S294988992400014X/pdfft?md5=db069b0efa6da4deaf55bbe919ddcd0d&pid=1-s2.0-S294988992400014X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2023-10-30DOI: 10.1016/j.jfop.2023.100060
Merrick J. Moseley , Catherine E. Stewart , Laura C. Bradley , Alistair R. Fielder , Michael P. Wallace
{"title":"Personalised versus standardised dosing of occlusion therapy for amblyopia: A randomised controlled trial","authors":"Merrick J. Moseley , Catherine E. Stewart , Laura C. Bradley , Alistair R. Fielder , Michael P. Wallace","doi":"10.1016/j.jfop.2023.100060","DOIUrl":"10.1016/j.jfop.2023.100060","url":null,"abstract":"<div><h3>Objectives</h3><p>To compare a novel, model-based personalised dosing strategy (PDS) with a standardised (best practice) occlusion dosing strategy (SDS) for the treatment of childhood amblyopia. We have utilised archived clinical trial data sets to develop a statistical model that aims to optimise the prescription of occlusion therapy. This approach, whose effectiveness has not previously been evaluated, incorporates within its underlying model: patient age, severity and type of amblyopia.</p></div><div><h3>Methods</h3><p>Randomised, parallel group design with PDS and SDS arms each having within or pre-trial optical treatment. Actual worn occlusion for both PDS and SDS groups was objectively recorded using occlusion dose monitors (ODMs).</p></div><div><h3>Results</h3><p>Of the 94 initially enrolled participants, 50 were male, 44 female, mean [IQR] age 5.53 [4.79–6.02] years. The improvement in logMAR acuity in the 68 participants remaining in the trial subsequent to optical treatment and not having withdrawn did not differ (p = 0.641) between the PDS and SDS groups: median [IQR] improvement 0.250 [0.13−0.39] in the PDS group, 0.225 [0.14−0.32] in the SDS group. A subset (n = 28) of participants were objectively observed to have occluded for every day prescribed. In these, we found that, after allowing for slightly higher prescribed doses of occlusion in the SDS group, adherence in the PDS group to be ∼20% greater than in the SDS group.</p></div><div><h3>Conclusion</h3><p>Whilst the PDS and SDS groups demonstrated equivalent visual performance and temporal outcomes, there is evidence that the PDS results in improved adherence with therapy likely to have arisen due to increased patient engagement with this novel regimen.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100060"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889923000600/pdfft?md5=daf7b7d7a67b2959d7451aba050b3dee&pid=1-s2.0-S2949889923000600-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136128017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-02-02DOI: 10.1016/j.jfop.2023.100062
Cindy Asayo Takigawa , Samuel Gelnick , Talia R. Kaden
{"title":"Chronic vascular remodeling in a case of ocular toxocariasis","authors":"Cindy Asayo Takigawa , Samuel Gelnick , Talia R. Kaden","doi":"10.1016/j.jfop.2023.100062","DOIUrl":"https://doi.org/10.1016/j.jfop.2023.100062","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100062"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889923000624/pdfft?md5=7a5664237af11a0a50cd3c63b0efa8a7&pid=1-s2.0-S2949889923000624-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139675164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JFO Open OphthalmologyPub Date : 2024-03-01Epub Date: 2024-01-22DOI: 10.1016/j.jfop.2024.100080
Kshitija Mundle , Brian Yu , Monali S. Malvankar-Mehta
{"title":"Impact of the pandemic on clinical management of glaucoma","authors":"Kshitija Mundle , Brian Yu , Monali S. Malvankar-Mehta","doi":"10.1016/j.jfop.2024.100080","DOIUrl":"10.1016/j.jfop.2024.100080","url":null,"abstract":"<div><h3>Objective</h3><p>To conduct a systematic review looking into the effects of the COVID-19 pandemic on the clinical management of glaucoma.</p></div><div><h3>Methods/analysis</h3><p>Literature was thoroughly searched through MEDLINE, CINAHL, Google Scholar, EMBASE, and ClinicalTrials.gov until August 5, 2020. Two levels of screening were performed independently by two authors. Kappa Statistics were used to test interrater reliability at each level of screening. The included articles were assessed for risk of bias using a checklist by CLARITY group. Data were extracted from the included articles and qualitative analysis was conducted.</p></div><div><h3>Results</h3><p>A total of 224 records were screened based on the Title/Abstract screening leaving 17 records. These 17 records went through Full-Text screening leaving 9 records for qualitative analysis. The articles outlined the barriers, recommended guidelines, and implemented guidelines used in glaucoma management during the COVID-19 pandemic. Five key pieces of information were extracted from the studies. First, the barriers to glaucoma management during the COVID-19 pandemic were extracted from all the articles. Second, pre-diagnosis and outpatient management protocols were extracted from seven of the articles. Third, specific hygiene and protective protocols that were followed during diagnosis and treatment, such as for clinical examinations, gonioscopy, tonometries, and personal protective equipment used were extracted from five of the articles. Fourth, telemedicine approaches to the management of glaucoma were extracted from four of the articles. Fifth, comprehensive information on the disinfection and sanitization protocol used in the clinical management of glaucoma was extracted from five articles.</p></div><div><h3>Conclusion</h3><p>Multiple healthcare organizations are taking sound steps in changing the clinical management of glaucoma during the COVID-19 pandemic. More studies on pre-diagnosis, outpatient management, specific hygiene, and disinfection and sanitization protocol will be helpful to ensure safer use of the equipment and effective glaucoma management in these challenging times.</p></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"5 ","pages":"Article 100080"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949889924000047/pdfft?md5=2af7aa4a65462068b3da325edb09d0d5&pid=1-s2.0-S2949889924000047-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139637139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}